Gilder Gagnon Howe & CO LLC Kymera Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

$8.56 Billion
Q4 2024

A detailed history of Gilder Gagnon Howe & CO LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 326,349 shares of KYMR stock, worth $10.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

326,349

Previous 291,340 12.02%

Holding current value

$10.3 Million

Previous $13.8 Million 4.79%

% of portfolio

0.15%

Previous 0.18%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$39.06 - $51.84 $1.37 Million - $1.81 Million	35,009 Added 12.02%	326,349 $13.1 Million
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $4.84 Million - $8.42 Million	160,611 Added 122.86%	291,340 $13.8 Million
Q2 2024 Aug 14, 2024	SELL	$29.85 - $39.42 $67,461 - $89,089	-2,260 Reduced 1.7%	130,729 $3.9 Million
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $3.05 Million - $5.79 Million	132,989 New	132,989 $5.35 Million
Q3 2023 Nov 14, 2023	SELL	$13.9 - $23.88 $95,451 - $163,983	-6,867 Reduced 7.74%	81,865 $1.14 Million
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $17,113 - $26,678	-764 Reduced 0.85%	88,732 $2.04 Million
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $17,139 - $26,737	-690 Reduced 0.77%	89,496 $2.65 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $175,973 - $278,032	8,992 Added 11.07%	90,186 $2.25 Million
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $290,209 - $475,633	-13,879 Reduced 14.6%	81,194 $1.77 Million
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $274,588 - $826,874	-19,433 Reduced 16.97%	95,073 $1.87 Million
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $192,279 - $352,311	-5,447 Reduced 4.54%	114,506 $4.85 Million
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $585,993 - $769,739	-11,741 Reduced 8.92%	119,953 $7.62 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $1.1 Million - $1.54 Million	23,116 Added 21.29%	131,694 $7.74 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $3.37 Million - $5.64 Million	108,578 New	108,578 $5.27 Million

Others Institutions Holding KYMR

# of Institutions

186

Shares Held

65.6M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.73B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account

Gilder Gagnon Howe & CO LLC Kymera Therapeutics, Inc. Transaction History